You searched for "papillomatosis"

44 results found

Laryngeal papillomatosis

Laryngeal papillomatosis remains one of the most frustrating conditions seen by laryngologists. Sam Majumdar gives us an overview of the current science and clinical practice. Human papilloma virus is a small (> 8kb) double stranded DNA virus with approximately 200...

The Airway Intervention Registry: Recurrent Respiratory Papillomatosis (AIR: RRP) data collection

Laryngeal papillomatosis remains a frustratingly difficult condition to treat. Adam Donne and Steven Powell tells us about a collaborative project aiming to enhance patient care. The first UK Recurrent Respiratory Papillomatosis registry opened in April 2018 through the AIR (Airway...

Gardasil vaccination as an adjuvant treatment for established recurrent laryngeal papillomatosis in male adults - does it stimulate an immune response?

Recurrent respiratory papillomatosis (RRP) is well known to be caused by infection with the human papilloma virus (types 6 and 11). Recurrence after surgical removal is common and potentially frequent and severe. Previous research has established that many patients with...

Gardasil vaccination for laryngeal RRP – an update

This paper reports the results of a follow-up study investigating the possible role of adjuvant Gardasil vaccination in patients with recurrent laryngeal papillomatosis. The preceding study – also published in the Journal of Voice (2017) – reported the changes in...

3rd European Laryngological Live Surgery Broadcast

News from Elisabeth V Sjögren, MD PhD, General Secretary European Laryngological Society Dept of Otolaryngology - Head & Neck Surgery, Leiden University Medical Centre, The Netherlands. The 3rd European Laryngological Live Surgery Broadcast, took place on 13 December 2017. The...

Do you treat RRP?

Do you treat RRP? Please join the national Airway Intervention Registry: Recurrent Respiratory Papillomatosis (AIR: RRP) online database. This is a unique opportunity to contribute to a collaborative, UK-wide study collecting real world data on treatments for this rare but...

HPV and ENT; should we vaccinate boys?

David Black and Charlie Hall reiterate Vin Paleri’s pleas for a common sense evidence-based approach by those who allocate healthcare resources to the now urgent issue of HPV-related disease. They discuss the merits of different vaccines and the need for...

BLA Position Statement - Interview with Mark Watson

Author and interviewer: Stefan Linton, ENT Registrar, Manchester Royal Infirmary. We caught up with Mark Watson, President of the British Laryngology Association, to find out his thoughts on the BLA’s position statement on the use of Gardasil vaccination in the...

From the editor NovDec 2019

Declan Costello, MA, MBBS, FRCS(ORL-HNS), Editor, ENT & Audiology News; Consultant Ear, Nose and Throat Surgeon, Wexham Park Hospital, Slough, Berkshire, UK. E: d.costello@nhs.net Welcome There are many jokes told by anaesthetists about surgeons, and perhaps even more in the...

An update on HPV and the vaccination

In recent years, the role of HPV in the development of oropharyngeal cancers has become apparent. Hannah Fox and Vin Paleri contend that while we may not always be able to cure oropharyngeal cancers, vaccination offers our best hope for...

Gardasil vaccination – an effective adjuvant therapy for RRP?

The clinical manifestations of recurrent respiratory papillomatosis (RRP) can vary hugely from individual to individual. Whilst some affected children will outgrow the disease, a subset of patients will experience frequent recurrences and require multiple surgical procedures over the course of...

55th South African ENT Congress - Incorporating SORSSA

Report by: Nic Goncalves, ENT Registrar, University of Cape Town. The 55th annual South African ENT congress was a great success. The congress was held at the Coastlands Hotel and Convention Center in Umhlanga, Durban. The event was organised by...